SCHEMBL2482051

SCHEMBL2482051

COC(=O)c1cc(Br)ccc1-c1ccc(Br)cc1C(=O)OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 1/20 0.54
▸ SLC6A3 Q01959 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ HSD17B10 Q99714 3/20 0.49
▸ CYP46A1 Q9Y6A2 1/20 0.46
▸ CHEK1 O14757 1/20 0.44
▸ TSHR P16473 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA7 P43166 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12737920 0.91 SLC6A3 (0.66) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL1577095 0.89 SLC6A3 (0.69) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL30580716 0.86 NR4A2 (0.47) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL3168568 0.86 SLC6A3 (0.65) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL20043732 0.86 NR4A2 (0.47) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL21102274 0.86 SLC6A3 (0.60) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL21102267 0.86 SLC6A3 (0.52) NR4A2SLC6A3ALDH1A1GAASMN1; SMN2
SCHEMBL21102391 0.86 SLC6A3 (0.60) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL4577829 0.86 NR4A2 (0.56) NR4A2SLC6A3ALDH1A1GAACYP1A2
SCHEMBL29773857 0.86 NR4A2 (0.56) NR4A2SLC6A3ALDH1A1GAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9761820-B2 Polymer CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-09-12 — — US disclosed
US-9761820-B2 Polymer CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2017-09-12 — — US disclosed
US-20150028313-A1 POLYMER CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2015-01-29 — — US disclosed
US-20150028313-A1 POLYMER CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2015-01-29 — — US disclosed
WO-2013114118-A2 POLYMER CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2013-08-08 — — WO disclosed
EP-1717258-B1 DIHALIDE, POLYMER COMPOUND AND METHOD FOR PRODUCING SAME TOKYO INST TECH (JP) 2011-10-19 — — EP disclosed
US-7898163-B2 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2011-03-01 — — US disclosed
US-7898163-B2 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2011-03-01 — — US disclosed
US-7462683-B2 Dihalide, polymer compound and method for producing the same TOKYO INSTITUTE OF TECHNOLOGY (JP) 2008-12-09 — — US disclosed
US-20070185306-A1 Dihalide, polymer compound and method for producing the same TOKYO INSTITUTE OF TECHNOLOGY (JP) 2007-08-09 — — US disclosed
US-20070034832-A1 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2007-02-15 — — US disclosed
US-20070034832-A1 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2007-02-15 — — US disclosed
EP-1717258-A1 DIHALIDE, POLYMER COMPOUND AND METHOD FOR PRODUCING SAME Tokyo Institute of Technology (JP) 2006-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185306-A1 Dihalide, polymer compound and method for producing the same HSPA4L, HDHD5, MRPL21 NR4A2 1633/4885SLC6A3 1963/4885ALDH1A1 628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback